EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 123 filers reported holding EPIZYME INC in Q1 2019. The put-call ratio across all filers is 1.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,703,000 | +1180.5% | 1,158,204 | +904.9% | 0.01% | – |
Q1 2022 | $133,000 | -97.6% | 115,254 | -66.9% | 0.00% | -100.0% |
Q2 2020 | $5,597,000 | +1365.2% | 348,514 | +1314.3% | 0.03% | +1300.0% |
Q1 2020 | $382,000 | +72.1% | 24,643 | +39.6% | 0.00% | +100.0% |
Q2 2019 | $222,000 | +107.5% | 17,653 | +2.0% | 0.00% | – |
Q4 2018 | $107,000 | – | 17,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |